ACADIA PHARMACEUTICALS INC.

acadia-pharmaceuticals-inc-logo

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neuro... logical and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.
#SimilarOrganizations #People #Financial #Event #Website #More

ACADIA PHARMACEUTICALS INC.

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1993-07-16

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.acadia-pharm.com

Total Employee:
501+

Status:
Active

Contact:
(858) 558-2871

Email Addresses:
[email protected]

Total Funding:
811.73 M USD

Technology used in webpage:
SPF Google Tag Manager Domain Not Resolving Global Site Tag Mobile Non Scaleable Content Euro IPv6 Google Maps Google Maps API Cloudflare Hosting


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

laura-a-brege_image

Laura A. Brege Member Board of Directors @ Acadia Pharmaceuticals Inc.
Board_member
2008-06-01

not_available_image

Arvid Carlsson Scientific and Clinical Advisor @ Acadia Pharmaceuticals Inc.
Advisor

not_available_image

Paul Anderson Member of the Scientific and Clinical Advisory Board @ Acadia Pharmaceuticals Inc.
Advisor

lester-kaplan_image

Lester Kaplan Board of Directors @ Acadia Pharmaceuticals Inc.
Board_member

not_available_image

Michael T. Borer Board of Directors @ Acadia Pharmaceuticals Inc.
Board_member

herbert-y-meltzer_image

Herbert Y. Meltzer Scientific and Clinical Advisor @ Acadia Pharmaceuticals Inc.
Advisor

torsten-rasmussen_image

Torsten Rasmussen Board of Directors @ Acadia Pharmaceuticals Inc.
Board_member

not_available_image

Leslie L. Iversen Board of Directors @ Acadia Pharmaceuticals Inc.
Board_member

Current Employees Featured

elena-ridloff_image

Elena Ridloff
Elena Ridloff Executive Vice President, Chief Financial Officer @ Acadia Pharmaceuticals Inc.
Executive Vice President, Chief Financial Officer
2019-04-01

steve-davis_image

Steve Davis
Steve Davis Chief Executive Officer & Board Member @ Acadia Pharmaceuticals Inc.
Chief Executive Officer & Board Member

michael-yang_image

Michael Yang
Michael Yang EVP & Chief Commerical Officer @ Acadia Pharmaceuticals Inc.
EVP & Chief Commerical Officer
2017-03-01

spyros-papapetropoulos_image

Spyros Papapetropoulos
Spyros Papapetropoulos Chief Development Officer & Executive R&D Advisor @ Acadia Pharmaceuticals Inc.
Chief Development Officer & Executive R&D Advisor
2019-11-01

srdjan-stankovic_image

Srdjan Stankovic
Srdjan Stankovic President @ Acadia Pharmaceuticals Inc.
President
2018-11-01

not_available_image

Gudarz Davar
Gudarz Davar EVP, Head of Research & Development @ Acadia Pharmaceuticals Inc.
EVP, Head of Research & Development
2020-08-01

william-bill-m-wells_image

William (Bill) M. Wells
William (Bill) M. Wells Director @ Acadia Pharmaceuticals Inc.
Director

not_available_image

Mark R. Brann
Mark R. Brann Founder @ Acadia Pharmaceuticals Inc.
Founder

austin-d-kim_image

Austin D. Kim
Austin D. Kim Executive Vice President & General Counsel & Secretary @ Acadia Pharmaceuticals Inc.
Executive Vice President & General Counsel & Secretary
2018-01-01

mark-schneyer_image

Mark Schneyer
Mark Schneyer EVP & Chief Financial Officer @ Acadia Pharmaceuticals Inc.
EVP & Chief Financial Officer

Founder


not_available_image

Mark R. Brann

Stock Details


Company's stock symbol is NASDAQ:ACAD

Acquisitions List

Date Company Article Price
2020-08-25 CerSci Therapeutics CerSci Therapeutics acquired by Acadia Pharmaceuticals Inc. 52.5 M USD

Investors List

national-institute-of-neurological-disorders-and-stroke_image

National Institute of Neurological Disorders and Stroke

National Institute of Neurological Disorders and Stroke investment in Grant - Acadia Pharmaceuticals Inc.

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.

nomura-international_image

Nomura International

Nomura International investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Post-IPO Equity - Acadia Pharmaceuticals Inc.

abn-amro_image

ABN AMRO Fund

ABN AMRO Fund investment in Series F - Acadia Pharmaceuticals Inc.

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series F - Acadia Pharmaceuticals Inc.

ld-pensions_image

LD Pensions

LD Pensions investment in Series F - Acadia Pharmaceuticals Inc.

federated-investors_image

Federated Investors

Federated Investors investment in Series F - Acadia Pharmaceuticals Inc.

Official Site Inspections

http://www.acadia-pharm.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.9 K

Unable to get host informations!!!

Loading ...

More informations about "Acadia Pharmaceuticals Inc." on Search Engine

dfkcompany.com © 2022. All rights reserved